Credentialing

The Parkinson Study Group (PSG) is continually interested in expanding our clinical trial sites as opportunities for new Parkinson’s Disease studies become available. Regardless of location (hospital, community-based, academic, or private practice), the PSG seeks trained Parkinson’s disease investigators who are committed to and experienced in clinical trials.

Congratulations to our newest credentialed PSG members!

Credentialed April 2023

  • Julian Agin-Liebes, MD
  • Ka Loong Kelvin Au, MD, FRCPC
  • Bisena Bulica, DO
  • Ilia Itin, MD
  • Lilia Lovera MD
  • Giulietta Riboldi, MD, PhD
  • Daphne Robakis, MD
  • Scott Sperling, PsyD

Credentialed May 2023

  • Michiko Bruno, MD

Upcoming Credentialing Deadline

Quarterly application review:

June 12, 2023

All primary investigators on PSG studies must be credentialed, as well as sub-investigators.

Who Needs to be PSG Credentialed?

All primary investigators on PSG studies must be credentialed, as well as sub-investigators. Our credentialing committee meets quarterly to review all new applications.

Upcoming submission deadlines are as follows:

  • JUNE 12, 2023
  • SEPTEMBER 11, 2023
  • DECEMBER 11, 2023